Literature DB >> 32738137

Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019.

Christopher K C Lai1, Zigui Chen1, Grace Lui2,3, Lowell Ling4, Timothy Li2, Martin C S Wong5, Rita W Y Ng1, Eugene Y K Tso6, Tracy Ho2, Kitty S C Fung6, Siu T Ng2, Barry K C Wong6, Siaw S Boon1, David S C Hui2,3, Paul K S Chan1,3.   

Abstract

BACKGROUND: Self-collected specimens have been advocated to avoid infectious exposure to healthcare workers. Self-induced sputum in those with a productive cough and saliva in those without a productive cough have been proposed, but sensitivity remains uncertain.
METHODS: We performed a prospective study in 2 regional hospitals in Hong Kong.
RESULTS: We prospectively examined 563 serial samples collected during the virus shedding periods of 50 patients: 150 deep throat saliva (DTS), 309 pooled-nasopharyngeal (NP) and throat swabs, and 104 sputum. Deep throat saliva had the lowest overall reverse-transcriptase polymerase chain reaction (RT-PCR)-positive rate (68.7% vs 89.4% [sputum] and 80.9% [pooled NP and throat swabs]) and the lowest viral ribonucleic acid (RNA) concentration (mean log copy/mL 3.54 vs 5.03 [sputum] and 4.63 [pooled NP and throat swabs]). Analyses with respect to time from symptom onset and severity also revealed similar results. Virus yields of DTS correlated with that of sputum (Pearson correlation index 0.76; 95% confidence interval, 0.62-0.86). We estimated that the overall false-negative rate of DTS could be as high as 31.3% and increased 2.7 times among patients without sputum.
CONCLUSIONS: Deep throat saliva produced the lowest viral RNA concentration and RT-PCR-positive rate compared with conventional respiratory specimens in all phases of illness. Self-collected sputum should be the choice for patients with sputum.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; diagnosis; saliva

Mesh:

Substances:

Year:  2020        PMID: 32738137      PMCID: PMC7454747          DOI: 10.1093/infdis/jiaa487

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  SARS-CoV-2 saliva testing using RT-PCR: a systematic review.

Authors:  Eyituoyo Okoturo; Mary Amure
Journal:  Int J Infect Dis       Date:  2022-05-13       Impact factor: 12.074

2.  Clinical Validation of a Sensitive Test for Saliva Collected in Health Care and Community Settings with Pooling Utility for Severe Acute Respiratory Syndrome Coronavirus 2 Mass Surveillance.

Authors:  Nikhil S Sahajpal; Ashis K Mondal; Sudha Ananth; Allan Njau; Pankaj Ahluwalia; Vamsi Kota; Kevin Caspary; Ted M Ross; Michael Farrell; Michael P Shannon; Sadanand Fulzele; Alka Chaubey; Madhuri Hegde; Amyn M Rojiani; Ravindra Kolhe
Journal:  J Mol Diagn       Date:  2021-05-04       Impact factor: 5.568

3.  COVID-19 screening in a healthcare or community setting: complexity of saliva as a specimen for PCR-based testing.

Authors:  Nikhil Shri Sahajpal; Ashis K Mondal; Allan Njau; Sudha Ananth; Salil Ghamande; Madhuri Hegde; Alka Chaubey; Amyn M Rojiani; Ravindra Kolhe
Journal:  Future Med Chem       Date:  2020-11-24       Impact factor: 3.808

Review 4.  Laboratory testing for the diagnosis of COVID-19.

Authors:  Christopher K C Lai; Wilson Lam
Journal:  Biochem Biophys Res Commun       Date:  2020-10-28       Impact factor: 3.575

Review 5.  How to recognize and respond to viral re-positivity and disease relapse in patients with COVID-19.

Authors:  Shiliang Zheng; Caide Liu; Yuhua Chi; Xiaodong Sun
Journal:  J Glob Health       Date:  2021-03-01       Impact factor: 4.413

6.  Public perception and performance of different sampling approaches for the diagnosis of COVID-19.

Authors:  Ngai Yung Tsang; Hau Chi So; Hiu Fai Ho; Gabriel M Leung; Dennis K M Ip
Journal:  Influenza Other Respir Viruses       Date:  2021-01-04       Impact factor: 4.380

Review 7.  Risk Factors for COVID-19 Mortality Among People Living with HIV: A Scoping Review.

Authors:  Karan Varshney; Prerana Ghosh; Helena Stiles; Rosemary Iriowen
Journal:  AIDS Behav       Date:  2022-01-13

Review 8.  The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).

Authors:  Narasimha M Beeraka; SubbaRao V Tulimilli; Medha Karnik; Surya P Sadhu; Rajeswara Rao Pragada; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

9.  High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and Children.

Authors:  Michael Huber; Peter Werner Schreiber; Thomas Scheier; Annette Audigé; Roberto Buonomano; Alain Rudiger; Dominique L Braun; Gerhard Eich; Dagmar I Keller; Barbara Hasse; Jürg Böni; Christoph Berger; Huldrych F Günthard; Amapola Manrique; Alexandra Trkola
Journal:  Microorganisms       Date:  2021-03-19

10.  SalivaSTAT: Direct-PCR and Pooling of Saliva Samples Collected in Healthcare and Community Setting for SARS-CoV-2 Mass Surveillance.

Authors:  Nikhil S Sahajpal; Ashis K Mondal; Sudha Ananth; Allan Njau; Pankaj Ahluwalia; Gary Newnam; Adriana Lozoya-Colinas; Nicholas V Hud; Vamsi Kota; Ted M Ross; Michelle D Reid; Sadanand Fulzele; Alka Chaubey; Madhuri Hegde; Amyn M Rojiani; Ravindra Kolhe
Journal:  Diagnostics (Basel)       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.